Douglas Thomson | Venture Partner
Kineticos Life Sciences

Douglas Thomson is a Venture Partner at infectious disease investor KAMRA.  He also serves as Chief Executive Officer and was a co-founder at Pneumagen a clinical stage infectious disease business. Prior to co-founding Pneumagen, he led executive teams generating rapid value creation. His background is in infectious disease vaccine research and development. He was previously at SingVax, in Singapore, as CEO, and Microscience Ltd as Business Development Director. Douglas currently sits on the board of Omideon, a St. Andrews, UK based biotech company focused on the development of novel treatments for cancer. He is also a non-executive director at EnteroBiotix, a microbiome therapeutics platform and product company.